Multimorbidity and healthcare utilisation among high-cost patients in the US Veterans Affairs Health Care System

Donna M Zulman, Christine Pal Chee, Todd H Wagner, Jean Yoon, Danielle M Cohen, Tyson H Holmes, Christine Ritchie, Steven M Asch, Donna M Zulman, Christine Pal Chee, Todd H Wagner, Jean Yoon, Danielle M Cohen, Tyson H Holmes, Christine Ritchie, Steven M Asch

Abstract

Objectives: To investigate the relationship between multimorbidity and healthcare utilisation patterns among the highest cost patients in a large, integrated healthcare system.

Design: In this retrospective cross-sectional study of all patients in the U.S. Veterans Affairs (VA) Health Care System, we aggregated costs of individuals' outpatient and inpatient care, pharmacy services and VA-sponsored contract care received in 2010. We assessed chronic condition prevalence, multimorbidity as measured by comorbidity count, and multisystem multimorbidity (number of body systems affected by chronic conditions) among the 5% highest cost patients. Using multivariate regression, we examined the association between multimorbidity and healthcare utilisation and costs, adjusting for age, sex, race/ethnicity, marital status, homelessness and health insurance status.

Setting: USA VA Health Care System.

Participants: 5.2 million VA patients.

Measures: Annual total costs; absolute and share of costs generated through outpatient, inpatient, pharmacy and VA-sponsored contract care; number of visits to primary, specialty and mental healthcare; number of emergency department visits and hospitalisations.

Results: The 5% highest cost patients (n=261,699) accounted for 47% of total VA costs. Approximately two-thirds of these patients had chronic conditions affecting ≥3 body systems. Patients with cancer and schizophrenia were less likely to have documented comorbid conditions than other high-cost patients. Multimorbidity was generally associated with greater outpatient and inpatient utilisation. However, increased multisystem multimorbidity was associated with a higher outpatient share of total costs (1.6 percentage points per affected body system, p<0.01) but a lower inpatient share of total costs (-0.6 percentage points per affected body system, p<0.01).

Conclusions: Multisystem multimorbidity is common among high-cost VA patients. While some patients might benefit from disease-specific programmes, for most patients with multimorbidity there is a need for interventions that coordinate and maximise efficiency of outpatient services across multiple conditions.

Keywords: GERIATRIC MEDICINE; HEALTH SERVICES ADMINISTRATION & MANAGEMENT; PRIMARY CARE.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Figures

Figure 1
Figure 1
Prevalence of body systems affected by chronic conditions and multisystem multimorbidity among high-cost VA patients (relative to remaining 95% of patients). Numbers at the top of each column represent the percentage of high-cost patients with one or more chronic conditions affecting the specified body system. Numbers within each cell represent the percentage of high-cost patients with chronic conditions affecting the dyad of body systems on both horizontal and vertical axes. Numbers in parentheses represent the relative prevalence when comparing high-cost patients with the remaining population. Shades highlight different prevalence levels, with darker shades representing higher rates (

Figure 2

Variation in number of comorbidities…

Figure 2

Variation in number of comorbidities among high-cost Veterans Affairs (VA) patients with common…

Figure 2
Variation in number of comorbidities among high-cost Veterans Affairs (VA) patients with common medical and mental health conditions (PTSD, post-traumatic stress disorder).
Figure 2
Figure 2
Variation in number of comorbidities among high-cost Veterans Affairs (VA) patients with common medical and mental health conditions (PTSD, post-traumatic stress disorder).

References

    1. Cohen S, Uberoi N. Differentials in the concentration in the level of health expenditures across population subgroups in the U.S., 2010. Rockville, MD: Agency for Healthcare Research and Quality Statistical Brief #421, 2013. (accessed 22 Jan 15).
    1. Joynt K, Gawande AA, Orav E et al. . Contribution of preventable acute care spending to total spending for high-cost Medicare patients. JAMA 2013;309:2572–8. 10.1001/jama.2013.7103
    1. Sommers A, Cohen M. Medicaid's High Cost Enrollees: How Much Do They Drive Program Spending? Washington, DC: Kaiser Commission for Medicaid and the Uninsured, 2006.
    1. Garber AM, MaCurdy TE, McClellan MB. Persistence of Medicare expenditures among elderly beneficiaries. In: Garber AM, ed. Frontiers in Health Policy Research. Vol 1 Cambridge, MA: MIT, 1998:153–80.
    1. Cohen S, Yu W. AHRQ Statistical Brief #354: The concentration and persistence in the level of health expenditures over time: Estimates for the US population, 2008–2009 2012. (accessed 28 Nov 2012).
    1. Coughlin T, Long S. Health care spending and service use among high-cost Medicaid beneficiaries, 2002–2004. Inquiry 2009;46:405–17.
    1. Hasselman D. Super-Utilizer Summit: Common Themes from Innovative Complex Care Management Programs. Hamilton, NJ: Center for Health Care Strategies, Inc., 2013.
    1. Kronick RG, Bella M, Gilmer TP et al. . The Faces of Medicaid II: recognizing the care needs of people with multiple chronic conditions. Center for Health Care Strategies, Inc., 2007.
    1. Powers BW, Chaguturu SK, Ferris TG. Optimizing high-risk care management. JAMA 2015;313:795–6. 10.1001/jama.2014.18171
    1. Centers for Medicare and Medicaid Services. Chronic Conditions among Medicare Beneficiaries. Chartbook: 2012 Edition. (accessed 2 Apr 2015).
    1. Kizer KW, Dudley RA. Extreme makeover: transformation of the veterans health care system. Annu Rev Public Health 2009;30:313–39. 10.1146/annurev.publhealth.29.020907.090940
    1. Asch SM, McGlynn EA, Hogan MM et al. . Comparison of quality of care for patients in the Veterans Health Administration and patients in a national sample. Ann Intern Med 2004;141:938–45. 10.7326/0003-4819-141-12-200412210-00010
    1. Phibbs CS, Bhandari A, Yu W et al. . Estimating the costs of VA ambulatory care. Med Care Res Rev 2003;60(3 Suppl):54–73. 10.1177/1077558703256725
    1. Wagner TH, Chen S, Barnett PG. Using average cost methods to estimate encounter-level costs for medical-surgical stays in the VA. Med Care Res Rev 2003;60(3 Suppl):15S–36S. 10.1177/1077558703256485
    1. Yu W, Wagner TH, Chen S et al. . Average cost of VA rehabilitation, mental health, and long-term hospital stays. Med Care Res Rev 2003;60(3 Suppl):40S–53S. 10.1177/1077558703256724
    1. Yoon J, Scott J, Phibbs CS et al. . Recent trends in Veterans Affairs chronic condition spending. Popul Health Manag 2011;14:293–8. 10.1089/pop.2010.0079
    1. Demakis J, McQueen L, Kizer K et al. . Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care 2000;38(6 Suppl 1):I17–25. 10.1097/00005650-200006001-00003
    1. Yu W, Ravelo A, Wagner TH et al. . Prevalence and costs of chronic conditions in the VA health care system. Med Care Res Rev 2003;60(3 Suppl):146S–67S. 10.1177/1077558703257000
    1. Yoon J, Zulman D, Scott JY et al. . Costs associated with multimorbidity among VA patients. Med Care 2014;52(Suppl 3):S31–6. 10.1097/MLR.0000000000000061
    1. Agency for Healthcare Research and Quality. HCUP Chronic Condition Indicator. Healthcare Cost and Utilization Project (HCUP) 2011. (accessed 17 Jul 2013).
    1. Steinman MA, Lee SJ, Boscardin WJ et al. . Patterns of multimorbidity in elderly veterans. J Am Geriatr Soc 2012;60:1872–80. 10.1111/j.1532-5415.2012.04158.x
    1. Papke LE, Wooldridge JM. Econometric methods for fractional response variables with an application to 401 (K) plan participation rates. J Appl Econ 1996;11:619–32. 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>;2-1
    1. Smith S, Soubhi H, Fortin M et al. . Interventions for improving outcomes in patients with multimorbidity in primary care and community settings. Cochrane Database Syst Rev 2012;4:CD006560.
    1. Grant RW, Adams AS, Bayliss EA et al. . Establishing visit priorities for complex patients: a summary of the literature and conceptual model to guide innovative interventions. Healthcare 2013;1:117–22. 10.1016/j.hjdsi.2013.07.008
    1. Guiding Principles for the Care of Older Adults with Multimorbidity: An Approach for Clinicians. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc 2012;60:E1–25. 10.1111/j.1532-5415.2012.04188.x
    1. Peterson D, Helfand M, Humphrey L et al. . Evidence Brief: Effectiveness of Intensive Primary Care Programs, VA-ESP Project #09–199. 2012.
    1. Brown RS, Peikes D, Peterson G et al. . Six features of Medicare coordinated care demonstration programs that cut hospital admissions of high-risk patients. Health Affairs (Project Hope) 2012;31:1156–66. 10.1377/hlthaff.2012.0393
    1. Boyd C, Leff B, Weiss C et al. . Clarifying multimorbidity patterns to improve targeting and delivery of clinical services for Medicaid populations. Center for Health Care Strategies, Inc., 2010.
    1. Hutter N, Schnurr A, Baumeister H. Healthcare costs in patients with diabetes mellitus and comorbid mental disorders—a systematic review. Diabetologia 2010;53:2470–9. 10.1007/s00125-010-1873-y
    1. Molosankwe I, Patel A, Jose Gagliardino J et al. . Economic aspects of the association between diabetes and depression: a systematic review. J Affect Disord 2012;142(Suppl):S42–55. 10.1016/S0165-0327(12)70008-3
    1. Hutter N, Knecht A, Baumeister H. Health: care costs in persons with asthma and comorbid mental disorders: a systematic review. Gen Hosp Psychiatry 2011;33:443–53. 10.1016/j.genhosppsych.2011.06.013
    1. Yohannes AM, Willgoss TG, Baldwin RC et al. . Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatric Psychiatry 2010;25:1209–21. 10.1002/gps.2463
    1. Medicare Payment Advisory Commission. Issues for risk adjustment in Medicare Advantage. Report to Congress: Medicare and the Health Care Delivery System Washington, DC, 2012.
    1. Chapko MK, Liu CF, Perkins M et al. . Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ 2009;18:1188–201. 10.1002/hec.1422
    1. Newcomer R, Clay T, Luxenberg JS et al. . Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. J Am Geriatr Soc 1999;47:215–19.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅